Mitsubishi UFJ Trust & Banking’s Krystal Biotech KRYS Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Buy	+757	New	+$226K	﹤0.01%	1231

Other funds holding KRYS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's KRYS Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Krystal Biotech (KRYS) in Q2 2026: 757 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #1231 among its holdings.

191 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 757 shares of Krystal Biotech worth $281K as of Q2 2026.
Krystal Biotech was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Krystal Biotech made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1231 holding.
191 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.